# Safety Study of F2695 SR in Major Depressive Disorder

> **NCT01034267** · PHASE3 · COMPLETED · sponsor: **Forest Laboratories** · enrollment: 828 (actual)

## Conditions studied

- Major Depressive Disorder

## Interventions

- **DRUG:** F2695 SR

## Key facts

- **NCT ID:** NCT01034267
- **Lead sponsor:** Forest Laboratories
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-12
- **Primary completion:** 2012-06
- **Final completion:** —
- **Target enrollment:** 828 (ACTUAL)
- **Last updated:** 2012-08-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01034267

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01034267, "Safety Study of F2695 SR in Major Depressive Disorder". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT01034267. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*